FIELD: immunology, pharmacology.
SUBSTANCE: the suggested composition includes virion anti-herpetic preparation that contains viruses of herpes simplex of 1 or 2 serotypes inactivated either with formalin or γ-radiation, moreover, the composition mentioned is supplemented with immunomodulator polyoxidonium; composition in question additionally contains valine and lysine and, also, the combination consisting of not less than 2 amino acids chosen out of the group of: phenylalanine, leucine, alanine, threonine, histidine, arginine, methionine at a certain ratio of components. The composition may additionally contain albumin and some vitamins. Another objective of the present innovation is the method to prepare a suppository based upon this pharmaceutical composition that includes mixing active components and cacao oil according to standard technique, moreover, as an active substance one should add the above-mentioned pharmaceutical composition and either one or several microelements chosen out of the following group: zinc, chromium, selenium and nickel. The innovation enables to keep antigenicity and stability of specific activity of the preparation mentioned along with enhanced antiviral properties; moreover, body resistance is increased and prolonged both in case of acute and chronic infection. New medicinal form of the composition suggested is easy for application.
EFFECT: higher efficiency of application.
6 cl, 4 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL ANTI-HERPETIC COMPOSITION | 2004 |
|
RU2291690C2 |
PHARMACEUTICAL COMPOSITION FOR PRODUCING ANTIHERPETIC MIXED VACCINE AND BASED DOSAGE FORM | 2014 |
|
RU2552341C1 |
CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
COMPOSITION COMPRISING LOW-MOLECULAR FRAGMENTS OF PEPTIDOGLICANE OF GRAM-NEGATIVE BACTERIA FOR PREVENTING OR TREATING OF HUMAN DISEASES | 2009 |
|
RU2441906C2 |
TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
PHARMACEUTICAL COMPOSITION WITH CYTOKINE AND IMMUNOMODULATING EFFECTS | 2002 |
|
RU2222345C2 |
METHOD OF PREPARING SUBSTANCE SHOWING IMMUNOSTIMULATING, ANTIVIRAL AND ANTIBACTERIAL ACTIVITY, SUBSTANCE OBTAINED BY THIS METHOD AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2195308C1 |
BROAD-SPECTRUM M2 PROTEIN ECTODOMAIN AVIAN INFLUENZA TYPE A VACCINE | 2014 |
|
RU2571944C1 |
RECOMBINANT TRIVALENT INFLUENZA VACCINE | 2012 |
|
RU2485973C1 |
ANTIVIRAL ACTIVITY OF FULLERENE AQUEOUS SOLUTION | 2018 |
|
RU2694754C1 |
Authors
Dates
2005-11-27—Published
2003-10-30—Filed